Home / Inspections / 1241625

FDA Inspection 1241625 — General Hospital Corporation (The)

General Hospital Corporation (The) — FEI 1270485

The FDA completed an inspection of General Hospital Corporation (The) on May 23, 2024 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)

Facility

Other inspections at this facility

  • 1110333 (NAI Wed Oct 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992257 (VAI Thu Oct 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 876646 (VAI Mon Apr 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 743401 (VAI Fri Aug 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources